Royal Chemistry India Profile
Key Indicators
- Authorised Capital ₹ 1.60 Cr
as on 28-06-2024
- Paid Up Capital ₹ 1.60 Cr
as on 28-06-2024
- Company Age 11 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 14.30%
(FY 2022)
- Profit 15.50%
(FY 2022)
- Ebitda 16.79%
(FY 2022)
- Net Worth 12.97%
(FY 2022)
- Total Assets 15.01%
(FY 2022)
About Royal Chemistry India
The Company is engaged in the Business Services Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.60 Cr and a paid-up capital of Rs 1.60 Cr, as per Ministry of Corporate Affairs (MCA) records.
Helen Abrahams, Ajit Sharma, Stephen Joyce, and One other member serve as directors at the Company.
- CIN/LLPIN
U74120KA2013FTC071506
- Company No.
071506
- Company Classification
Private Limited Foreign Company Incorporated In India
- Incorporation Date
21 Oct 2013
- Date of AGM
29 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangalore, Karnataka, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Royal Chemistry India?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Helen Abrahams  | Director | 13-Aug-2014 | Current |
Ajit Sharma  | Director | 17-Sep-2019 | Current |
| Stephen Joyce | Director | 15-Sep-2017 | Current |
| Paul Lewis | Director | 26-Nov-2020 | Current |
Financial Performance and Corporate Structure Insights of Royal Chemistry India.
Royal Chemistry India Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 14.3% increase. The company also saw a substantial improvement in profitability, with a 15.5% increase in profit. The company's net worth Soared by an impressive increase of 12.97%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Royal Chemistry India?
In 2020, Royal Chemistry India had a promoter holding of 100.00%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Royal Chemistry India FoundationActive 16 years 6 monthsHelen Abrahams, Ajit Sharma and 2 more are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Royal Chemistry India?
Royal Chemistry India has a workforce of 11 employees as of Mar 21, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Royal Chemistry India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Royal Chemistry India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
